Philippa Griffin
Philippa has a substantial prosecution practice before the European Patent Office (EPO), and she is responsible for the coordination and strategic management of complex worldwide patent portfolios covering commercially significant products. Philippa is also highly experienced in the conduct of offensive and defensive opposition and appeal proceedings before the EPO. Other aspects of her practice include drafting, freedom to operate, and opinion work. Philippa has particular expertise in handling inventions relating to antibodies and immunology; immunotoxin-based therapeutics; recombinant protein production and formulation; synthetic biology, gene editing, cloning, and sequencing technologies; rapid/bedside diagnostics; modified and thermostable enzymes; bone and cartilage regeneration; and vaccines. She acts for a diverse range of clients, including international biopharma and bioscience companies, SMEs, public sector organisations, and universities. · Mathys & Squire LLP
About
Partner at Mathys & Squire LLP with a substantial prosecution practice before the European Patent Office (EPO), responsible for coordinating and strategically managing complex worldwide patent portfolios and experienced in offensive and defensive opposition and appeal proceedings. She also advises on drafting, freedom-to-operate and opinion work and acts for international biopharma and bioscience companies, SMEs, public sector organisations and universities.
Practice areas
Office
Expertise
Education
- Master's degree in Natural Sciences (Zoology), Cambridge University (First Class)
- Certificate in Intellectual Property Law, University of London
Admissions
- Chartered Patent Attorney (qualified 2005)
- European Patent Attorney (qualified 2005)